Answers are grounded in this paper and cite their sources.
The addition of Osteopontin-c immunohistochemistry to standard pathology work-ups may have prognostic benefit in early breast cancer diagnosis.
No takes yet. Share an insight, caveat, or question.
Zduniak et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: